Re-investigating PLK1 inhibitors as antimitotic agents
Résumé
Polo-like kinase 1 (PLK1) plays key roles during mitosis, prompting the development of PLK1 inhibitors for anticancer therapy. We recently determined that PLK1 is crucially required for entry into mitosis. Hence, we discuss the potential and limitations of PLK1 inhibition strategies to promote mitotic arrest and death of cancer cells.
Domaines
Sciences du Vivant [q-bio]
Fichier principal
Re-investigating PLK1 inhibitors as antimitotic agents-3.pdf (1.84 Mo)
Télécharger le fichier
Origine : Publication financée par une institution
Licence : CC BY NC ND - Paternité - Pas d'utilisation commerciale - Pas de modification
Licence : CC BY NC ND - Paternité - Pas d'utilisation commerciale - Pas de modification